Anthony Bonavia
Penn State Milton S Hershey Med Ctr · Milton S. Hershey Medical Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Anthony Bonavia as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:14 UTC. Open this list on ClinicalTrials.gov
- N/ANCT03626870 · Effects of Resistin on Neutrophil FunctionMilton S. Hershey Medical Center · withdrawn · Inflammation · principal investigator
- N/ANCT03146546 · STUDY00015328: Sepsis EndotypesMilton S. Hershey Medical Center · enrolling by invitation · Sepsis · principal investigator
- N/ANCT02978378 · Renal Biomarkers to Predict Recovery Following Venoarterial Extracorporeal Membrane OxygenationMilton S. Hershey Medical Center · terminated · Acute Kidney Injury · principal investigator
- N/ANCT02624050 · Methohexital v Propofol as General Anesthetic in Patients on ACEIs or ARBsMilton S. Hershey Medical Center · completed · Hypotension, Anesthesia · principal investigator
- N/ANCT02553174 · AKI in Thoracic and Abdominal SurgeryMilton S. Hershey Medical Center · terminated · Acute Kidney Injury · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:14 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Integration of Immunologic Phenotyping with Computational Approaches to Predict Clinical Trajectory in Septic PatientsR35GM150695 · NIGMS · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · fiscal years 2023 to 2026 · $418,500 awarded in 2026Same name and institution; not confirmed by an ID
- Resistin-induced immunosuppression increases susceptibility to infectious lung injury and sepsis during AKIK08GM138825 · NIGMS · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · fiscal years 2020 to 2022 · $201,617 awarded in 2022Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:14 UTC. The ranking covers the 200 most relevant of 4 PubMed records, and a shared surname and initials can bring in a namesake. All 4 on PubMed
- Efficacy and safety of treatment with an anti-m2e monoclonal antibody in experimental human influenza.J Infect Dis · 2015114 citationsRCR 4.0
- RSM01, a novel respiratory syncytial virus monoclonal antibody: preclinical characterization and results of a first-in-human, randomised clinical trial.BMC Infect Dis · 202412 citationsRCR 2.0
- Esmolol infusion versus propranolol infusion: effects on heart rate and blood pressure in healthy volunteers.J Appl Physiol (1985) · 20177 citationsRCR 0.4
- A randomized controlled trial comparing methohexital and propofol for induction in patients receiving angiotensin axis blockade.Medicine (Baltimore) · 20194 citationsRCR 0.3